PD-L1 as a predictive biomarker for pembrolizumab in HER2-positive gastric or gastro-esophageal junction adenocarcinoma-a commentary on KEYNOTE-811
- PMID: 38859610
- DOI: 10.21037/cco-24-28
PD-L1 as a predictive biomarker for pembrolizumab in HER2-positive gastric or gastro-esophageal junction adenocarcinoma-a commentary on KEYNOTE-811
Keywords: Gastric cancer; PD-L1; gastro-esophageal junction cancer (GEJ cancer); pembrolizumab; predictive biomarker.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous